×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
House's updated biosecurity bill sets 2032 decoupling deadline for industry's work with WuXi AppTec, WuXi Biologics
Fierce Pharma
The amended BIOSECURE Act adds WuXi Biologics to its targets and gives biopharma companies until the start of 2032 to halt work with the two...
4 days ago
US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties
Reuters
A new version of a congressional bill that would restrict U.S. business with certain Chinese biotechnology companies including WuXi AppTec...
4 days ago
U.S. Biosecure Act Advances With Revised Timeline
Contract Pharma
WuXi Biologics added to list of biotech companies of concern, now provides U.S. companies until 2032 to find new service providers.
10 hours ago
How WuXi AppTec is battling the Biosecure Act
BioCentury
WuXi AppTec is pushing back on calls from members of Congress for the Pentagon to consider adding the company and its subsidiaries to the...
4 days ago
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling
WSJ
The revised bill also added WuXi Biologics to the list of biotech companies of concern on which the restrictions would apply.
1 day ago
BIOSECURE Act Gets Update, Gives US Drugmakers Until 2032 to Sever Ties with Chinese Biotechs
BioSpace
An updated draft of the BIOSECURE Act introduced on Friday would give U.S. drug manufacturers additional leeway for existing contracts with...
1 day ago
Political winds shift on China, biotech lobby changes tack on WuXi
STAT
WASHINGTON — In the photo, the two men are grinning widely: the CEO of WuXi Biologics and the incoming CEO of the biotechnology industry's...
4 weeks ago
WuXi Biologics Named to CDP 'A List' for Water Security
PR Newswire
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment. WuXi Biologics ("WuXi Bio") (2269. HK), a leading global...
1 month ago
WuXi Biologics achieves large-scale manufacturing milestone
European Pharmaceutical Review
A combination of four 4,000-litre single-use bioreactors reaching a 16,000-litre scale has resulted in the successful completion of WuXi...
3 months ago
WuXi Biologics withdraws from 2024 BIO convention amid worsening geopolitical tensions
Fierce Pharma
Amid a U.S. biosecurity crackdown, Chinese CDMO WuXi Biologics has quietly exited what is perhaps the biotech industry's biggest event of...
2 weeks ago